HEALTHJul 14 · 20:00 UTCSCIENTIFIC AMERICAN

Experimental immune therapy shows promise against deadly childhood brain cancer

An experimental immune therapy showed promise against a deadly childhood brain cancer, with children having aggressive recurrent brain tumors remaining disease-free years after treatment in an early-stage trial.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Experimental immune therapytopicdeadly childhood brain cancertopicaggressive recurrent brain tumorstopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHApr 30 · 00:00 UTC
Long-lived immune cells show promise against cancer in world-first trial
HEALTHJul 8 · 05:28 UTC
Brain tumors: New vaccine offers patients hope for more time
HEALTHMay 21 · 00:00 UTC
Did a boy’s life-saving gene therapy cause his brain tumour?
HEALTHMay 31 · 09:26 UTC
'Striking' cancer jabs destroys tumours in treatment-resistant cases in trial